Technology News and Research

RSS

Study shows AI systems can accurately identify and grade prostate cancer

Researchers at Karolinska Institutet in Sweden have together with international collaborators completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer.

13 Jan 2022

Government funding supports national effort to vaccinate vulnerable communities

Community Vaccine Champions from Bradford to Brighton will be tapping into their local networks and encouraging people in their community to come forward and get vaccinated.

13 Jan 2022

KHN’s ‘What the Health?’: Dealing with drug prices

Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer's drug, to only patients participating in approved clinical trials.

13 Jan 2022

New and improved method for imaging the structure of neural connections

The glory of tissue expansion technologies is that when structures, such as proteins that build nerve cell connections, are too small for a microscope to resolve, clever chemistry can make everything bigger and easier to see.

13 Jan 2022

UC researchers to examine how stress hormones affect cell degeneration in Parkinson's patients

Stress can have a negative effect on anyone's health but presents particular challenges for people with Parkinson's disease.

13 Jan 2022

New trial could transform the way of caring for people with neuroendocrine tumors

A revolutionary new way of caring for people with neuroendocrine tumors (NETs) will be trialed in the coming months, with the Flinders University-led project aiming to improve patient quality of life and develop a cost-effective system that can be implemented across other rare cancers in the future.

13 Jan 2022

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.

From Malvern Panalytical 13 Jan 2022

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

In this study, researchers identified and recruited volunteers who received inactivated COVID-19 vaccines in real-world settings.

13 Jan 2022

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours - a feat that's nearly unheard of in standard clinical care.

13 Jan 2022

How did the COVID pandemic affect the spread of other zoonotic diseases?

In new research, scientists from the Beijing University of Technology have been investigating the impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Their work is published in the journal BMJ Global Health.

12 Jan 2022

Wearable sweat sensors can help assess an individual's health

Sweating it out through exercise may be a New Year's resolution but it could also help to provide new insights into the state of your health, according to new sensing technology being developed at Simon Fraser University.

12 Jan 2022

Link between two key parts of the brain plays a role in neuropsychiatric brain disorders

Florida State University researchers have identified a link between two key parts of the brain that play significant roles in conditions such as Alzheimer's disease, post-traumatic stress disorder, schizophrenia and depression.

12 Jan 2022

Newly designed biochip simplifies the process of manufacturing in vitro skin in the laboratory

Researchers from the Universidad Carlos III de Madrid, the Universidad Politécnica de Madrid (UPM) and other entities have designed a new biochip, a device that simplifies the process of manufacturing in vitro skin in the laboratory and other complex multi-layer tissues.

12 Jan 2022

New type of blood test can be used to detect cancers as well as metastatic disease

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.

12 Jan 2022

Excelitas technologies introduces µPAX-3 Pulsed Xenon Light Source

Excelitas Technologies Corp., a leading industrial technology manufacturer focused on delivering innovative, market-driven photonic solutions, announces the new µPAX-3 Pulsed Xenon Light Source.

From Excelitas Technologies 12 Jan 2022

TetraScience announces 300% ARR growth and 2021 achievements; prepares for next phase of growth

TetraScience, the R&D Data Cloud Company, is pleased to share highlights from a record-breaking 2021 fiscal year, including 300% annual recurring revenue growth, an $80M Series B funding round, and full operationalization of the Tetra Partner Network.

From TetraScience, Inc. 12 Jan 2022

Flowmeter Solutions for High-Speed Batch Dosing

Titan Enterprises has published a white paper reporting on an investigation into the use of electronic flow meters in high-speed batching processes.

From Titan Enterprises Ltd 12 Jan 2022

Telemedicine at Johns Hopkins Medicine enables a stroke patient to be treated with high level of care

A patient believed to have suffered a stroke typically gets transported to the nearest emergency room for tests to determine the best course of action. Telemedicine at Johns Hopkins Medicine enabled one patient to have her stroke diagnosed and a treatment plan set up without ever stepping foot in a hospital.

11 Jan 2022

New passive air sampler clip can help assess personal exposure to SARS-CoV-2

Masks, social distancing, proper hygiene and ventilation can help reduce the transmission of COVID-19 in public places, but even with these measures, scientists have detected airborne SARS-CoV-2 in indoor settings.

11 Jan 2022

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen receptor macrophage (CAR-M) has helped to establish the viability of this innovative immunotherapy, which advances the trailblazing scientific discovery of CAR T cell therapy- also pioneered at Penn- for solid cancer tumors and offers a promising new strategy in the fight against cancer.

11 Jan 2022

Technology News and Research

Study shows AI systems can accurately identify and grade prostate cancer

Government funding supports national effort to vaccinate vulnerable communities

KHN’s ‘What the Health?’: Dealing with drug prices

New and improved method for imaging the structure of neural connections

UC researchers to examine how stress hormones affect cell degeneration in Parkinson's patients

New trial could transform the way of caring for people with neuroendocrine tumors

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

How did the COVID pandemic affect the spread of other zoonotic diseases?

Wearable sweat sensors can help assess an individual's health

Link between two key parts of the brain plays a role in neuropsychiatric brain disorders

Newly designed biochip simplifies the process of manufacturing in vitro skin in the laboratory

New type of blood test can be used to detect cancers as well as metastatic disease

Excelitas technologies introduces µPAX-3 Pulsed Xenon Light Source

TetraScience announces 300% ARR growth and 2021 achievements; prepares for next phase of growth

Flowmeter Solutions for High-Speed Batch Dosing

Telemedicine at Johns Hopkins Medicine enables a stroke patient to be treated with high level of care

New passive air sampler clip can help assess personal exposure to SARS-CoV-2

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News